15-PGDH Inhibitors

Our company offers a range of advanced 15-PGDH inhibitors which are specifically designed to target the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) By inhibiting this enzyme our inhibitors help to regulate the levels of prostaglandins which are important signaling molecules involved in various biological processes Through their targeted action our 15-PGDH inhibitors have the potential to provide therapeutic benefits in conditions where prostaglandin dysregulation is implicated such as inflammation pain and certain types of cancer

Catalog Number	Chemical Name	CAS #	Price
EI-2089	SW-033291	459147-39-8	Online Inquiry
EI-2360	β-Glycyrrhetinic acid	471-53-4	Online Inquiry

Application

15-PGDH inhibitors are valuable tools in cancer research and potentially offer therapeutic potential By inhibiting the activity of the enzyme 15-PGDH these inhibitors can prevent the breakdown of prostaglandin E2 (PGE2) a molecule that plays a crucial role in promoting tumor growth and preventing the immune system from attacking cancer cells Researchers can use 15-PGDH inhibitors to study the effects of elevated PGE2 levels on cancer progression and explore their potential as anti-cancer therapies By blocking 15-PGDH these inhibitors have the potential to disrupt tumor growth and enhance the body's immune response against cancer thus offering promising new avenues for treating this devastating disease

Please note that all services are for research use only. Not intended for any clinical use.

15-PGDH Inhibitors